Risk factors of bronchial asthma, chronic obstructive lung disease and «OVERLAP» syndrome asthma-COPD among adults in Ekaterinburg
- 作者: Abdullaev V1, Beltyukov E2, Naumova V3
-
隶属关系:
- MBU CGKB No. 1
- Ural State Medical University
- MAHCI CCH № 40
- 期: 卷 15, 编号 4 (2018)
- 页面: 26-29
- 栏目: Articles
- URL: https://journals.rcsi.science/raj/article/view/120454
- DOI: https://doi.org/10.36691/RJA133
- ID: 120454
如何引用文章
详细
Topicality. Prevalence of bronchial asthma (BA) and COPD achieves in different countries 18 and 20% respectively. The prevalence of «OVERLAP» syndrome - ASTHMA/COPD in Russia is unknown. Objective. To determine the prevalence ofBA, COPD and «OVERLAP» syndrome - ASTHMA/COPD. Materials and methods. The study included a survey using a specially developed questionnaire to identify asthma-like symptoms (ALS), risk factors for BA, COPD, and the definition of FEV^ FEV^FVC in adults in Ekaterinburg. Results. The study has revealed that the risk factors for developing ALS are exposure to tobacco smoke and age over 40 years. The impact of allergens and family history of allergy are less significant. Decrease of spirometry indices is associated with smoking, age over 40 years and the presence of ALS. The diagnostic criteria for the «OVERLAP» syndrome - ASTHMA/COPD were developed based on the answers to the questionnaire on ALS, risk factors and the results of the screening spirometry. Conclusions. Preliminary prevalence ofBA, COPD, «OVERLAP» syndrome - ASTHMA/COPD and actual risk factors have been established in Ekaterinburg in 2018. Unfavorable situation with prevalence of smoking in Ekaterinburg has been showing.
作者简介
V Abdullaev
MBU CGKB No. 1врач-пульмонолог терапевтического отделения.
E Beltyukov
Ural State Medical Universityдоктор медицинских наук, профессор кафедры факультетской терапии и эндокринологии.
V Naumova
MAHCI CCH № 40
Email: nika.naumova@gmail.com
кандидат медицинских наук, врач аллерголог-иммунолог консультативно-диагностической поликлиники.
参考
- Чучалин А.Г. Достижения в лечении астмы в России в первой декаде нового тысячелетия. Consilium Medicum. 2010;(экстравыпуск):11-12.
- Buist AS, McBumie MA, Vollmer WM. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-750.
- Ohuchalin AG. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. International Journal of COPD. 2014;9:963-974.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Initiative for Chronic Obstructive Lung Diseases. 2011:80.
- Pene J. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008;180:7423-7430.
- NMH/MND/CPM/13.1 Global alliance against chronic respiratory diseases (GARD) 7th General Meeting, 9-10 July 2012, St. Petersburg, Russia. http://www.who.int/gard/ publications.
- Viegi G, Matteelli G, Angino A. The proporthional Venn diagram of obstructive Lung disease in the Italian general population. Chest. 2004;126(4):1093-10101.
- Аллергология. Федеральные клинические рекомендации. Главные редакторы: акад. РАН РМ. Хаитов, проф. Н.И. Ильина. М.: «Фармарус Принт Медиа». 2014, 126 с.
- Brozek JL, Bousquet J, Agache I et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines - 2016 Revision. J Allergy Clin Immunol. 2017;140(4). DOI: 10.1016/j. jaci.2017.03.050.
- Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203-2217.